
样式: 排序: IF: - GO 导出 标记为已读
-
Pharmacological Strategies for the Management of Severe Alcohol-associated Hepatitis: A Systematic Review and Meta-analysis Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-06-13 Alvi H. Islam, Claudia Alvizuri, Hailemichael Desalegn, Emily Stephenson, Francisco Idalsoaga, Luis Antonio Diaz, John K. MacDonald, Gene Y. Im, Ashwani K. Singal, Vipul Jairath, Mohammad Qasim Khan, Juan Pablo Arab
Alcohol-associated hepatitis (AH) is a severe form of alcohol-associated liver disease, with a short-term mortality of up to 50% within three months. The aim of this systematic review was to determine the optimal pharmacological treatment for severe AH that results in better survival outcomes.
-
Perianal Disease in Pediatric-Onset Crohn’s Disease: Incidence, Disease Course, and Long-Term Outcomes Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-06-13 Annika Ström, Sabine Jansson, Mads Damsgaard Wewer, Johan Burisch, Mikkel Malham, Vibeke Wewer
Perianal Crohn's disease (CD) is characterized by fistulae and/or abscesses in the anal region and leads to significant morbidity. We aimed to estimate the incidence and describe the disease course of perianal disease in pediatric-onset CD.
-
Stable Trends in Incidence of Young-Onset Esophageal Adenocarcinoma: A Twenty-Year Analysis from the United States Cancer Statistics Database Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-06-13 Anila Vasireddy MBBS, Yazan Abboud MD, Prasad G. Iyer MD MS, Srinivas Gaddam MD, Amrit K. Kamboj MD
-
Intestinal Ultrasound and Its Advanced Modalities in Characterizing Strictures in Crohn's Disease Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-06-13 F. de Voogd, K.J. Beek, M. Pruijt, K. van Rijn, J. van der Bilt, C. Buskens, W. Bemelman, A. Neefjes-Borst, A. Mookhoek, G. D’Haens, J. Stoker, K.B. Gecse
Crohn’s disease (CD) strictures exhibit varying levels of inflammation and chronicity. We evaluate whether intestinal ultrasound (IUS) is accurate in characterizing stricture composition.
-
Psychomotor development in infants following maternal exposure to biologics: Results from the DUMBO registry Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-06-13 Laura Palomino, Marta Velasco Rodríguez-Belvís, María José Casanova, Eduardo Leo-Carnerero, Cristina Calviño Suarez, Montserrat Rivero, Marta Calvo, María Teresa Arroyo, Agnes Fernández-Clotet, Isabel Pérez-Martínez, Ángeles Masedo González, Vicent Hernández, Alexandra Ruiz-Cerulla, Pilar López Serrano, Pablo Vega, Iago Rodríguez-Lago, Raquel Vicente Lidón, Miguel Ángel De Jorge, Iván Guerra, Lara
The impact of biologic treatment for inflammatory bowel disease (IBD) during pregnancy and lactation on infant psychomotor development is barely studied. We investigated the effect of exposure to biologics in utero or during breastfeeding on the psychomotor development of offspring during their first year
-
ALT is an effective screening tool for advanced MASLD in children with obesity and overweight Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-06-13 Anne-Sophie R. Stroes, Laura Draijer, Malika Chegary, Felix Kreier, Erim van Os, Joery Goede, Venje Boonstra, Ilse Westerbeek, Saskia Bouma, Meeike Kusters, Roosje Roelants, Ulrich Beuers, Adriaan G. Holleboom, Marc A. Benninga, Bart G.P. Koot
Metabolic dysfunction-associated steatotic liver disease (MASLD) is common in children with obesity and overweight. However, neither the optimal method nor risks and benefits of screening have been established. This study aims to evaluate the effectiveness of an Alanine Aminotransferase (ALT)-based screening algorithm for detecting those at risk of significant fibrosis.
-
Yield of Advanced Neoplasia at 2nd Post-Polypectomy Surveillance Colonoscopy: A Systematic Review and Meta-Analysis Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-06-13 Pooja Pandita, Yi Le, Mehul Trivedi, Karen Heskett, Joshua Demb, Siddharth Singh, Brian A. Sullivan, Lin Liu, Samir Gupta
Individuals who have had polypectomy and at least one surveillance colonoscopy exam are routinely encountered, but evidence to inform risk for subsequent neoplasia and timing of surveillance is limited. Our aim was to conduct a systematic review and meta-analysis of serial surveillance yield.
-
Addition of AFP Improves Sensitivity of Ultrasound for Early-Stage HCC Detection in Patients with Cirrhosis Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-06-12 Akash Patel, Darine Daher, Sruthi Yekkaluri, Michelle Ng, Nicole E. Rich, Amit G. Singal
-
Janus kinase (JAK) inhibitor-induced acne in inflammatory bowel disease – an international, multicenter, retrospective cohort study Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-06-11 Sailish Honap, Maria José Temido, Eathar Shakweh, Fakhirah Badrulhisham, Natalie Shields, Sonia Mehta, Jodie McBride, Mathieu Uzzan, Milan Lukáš, Mathurin Fumery, Akira Nogami, Taku Kobayashi, Stephane Nancey, Joana Camões Neves, João Martins Mendes, Birte-Antina Wegener, Emilie Bergereau, Rita Fernandes, Anish John Kuriakose Kuzhiyanjal, Sophie Vieujean, Ashley Spencer, Samantha Baillie, Maria Manuel
JAK inhibitor-associated acne is a common but poorly understood adverse event. This study aimed to investigate the epidemiology, clinical characteristics, and treatment outcomes of this condition in patients with inflammatory bowel disease (IBD).
-
Primary Prevention of Pouchitis Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-29 Edward L. Barnes, Hans Herfarth
-
Adverse Events After Surveillance Colonoscopy in Older Adults in a Large Integrated Health System in the United States Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-27 Jeffrey K. Lee, Christopher D. Jensen, Sophie A. Merchant, Jessica Chubak, Ethan A. Halm, Douglas A. Corley, National Cancer Institute’s PROSPR Consortium, Joanne E. Schottinger, Celette Sugg Skinner
-
Reply letter to Matheus Souza et al Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-21 Marilia De Brito Gomes, Bianca Barros PhD
-
Performance of a Smartphone-based Stool Test For Use in Colorectal Cancer Screening: Population-based Study Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-20 Michael Hoffmeister, Teresa Seum, Leopold Ludwig, Hermann Brenner
Noninvasive colorectal cancer (CRC) screening bears high potential for increasing participation if implemented in a straightforward way. We have evaluated the feasibility and diagnostic performance of a smartphone-based fecal immunochemical test (FIT) for CRC screening and compared its performance with a laboratory-based FIT.
-
Global Epidemiology of Primary Biliary Cholangitis: An Updated Systematic Review and Meta-analysis Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-19 Jarell Jie-Rae Tan, Ambrose Hon Lam Chung, Jing Hong Loo, Joo Wei Ethan Quek, Sagar Sharma, Corrine Lee Singh, Roe Xin Jacqueline Yap, Wei Xuan Tay, Matthew K. Smith, Ellina Lytvyak, Andrew Mason, Aldo J. Montano-Loza, Yu Jun Wong
Primary biliary cholangitis (PBC) demonstrates significant geographical variability in its epidemiology. We aim to provide an updated estimate on the global and temporal trends of the prevalence and incidence of PBC from 1976 to 2024.
-
PErsistence and safety of subcutaneous infliximab 1 year after switch from intravenous route in IBD patients in REMission Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-19 Nicolas Mathieu, Marianne Hupé, Frédéric Heluwaert, Pauline Rivière, Xavier Hébuterne, Antoine Chupin, Vered Abitbol, Guillaume Bouguen, Lucine Vuitton, Jean-Marc Gornet, Céline Montuclard, Stéphane Nancey, Guillaume Cadiot, Pauline Wils, Cyrielle Gilletta, Astrid de Maissin, Romain Altwegg, Elise Chanteloup, Laurianne Plastaras, Philippe Ah Soune, Arnaud Bourreille, Carmen Stefanescu, Philippe Seksik
Real-life data regarding inflammatory bowel disease (IBD) evolution after switch from intravenous infliximab (IV-IFX) to subcutaneous infliximab (SC-IFX) is necessary. The aim of this prospective multicenter cohort study was to describe the persistence, effectiveness and tolerance of SC-IFX after switch from IV-IFX.
-
Transferrin Saturation and Serum Ferritin Are Main Predictors of Liver Iron Content in Subjects With Hyperferritinemia Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-19 Giulia Risca, Sara Pelucchi, Raffaella Mariani, Mara Botti, Giulia Capitoli, Filiberto Di Gennaro, Stefania Galimberti, Alberto Piperno
Hyperferritinemia is widespread and is caused by or associated with a variety of diseases requiring complex diagnostic workup. Magnetic resonance imaging–based liver iron quantification (LICMRI) can differentiate subjects with iron overload requiring treatment but is still limited to specialized centers and costly. We aimed to determine whether parameters belonging to the diagnostic setting of hyperferritinemia
-
AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-19 Qasim Aziz, Lucinda A. Harris, Brent P. Goodman, Magnus Simrén, Andrea Shin
The purpose of this Clinical Practice Update Expert Review is to describe key principles in the evaluation and management of patients with disorders of gut-brain interaction (DGBI) and hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorders (HSDs) with coexisting postural orthostatic tachycardia syndrome (POTS) and/or mast cell activation syndrome (MCAS).
-
pH Impedance Monitoring on Proton Pump Inhibitor Therapy Impacts Management Decisions in Proven GERD but not in Unproven GERD Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-16 C. Prakash Gyawali, Benjamin D. Rogers, Rena Yadlapati, Sabine Roman, Dustin A. Carlson, John Pandolfino
Ambulatory reflux monitoring off proton pump inhibitors (PPIs) is useful in unproven gastroesophageal reflux disease (GERD). In this prospective clinical trial, we evaluated if on-PPI pH-impedance monitoring provides value in unproven GERD.
-
Primary Pancreatic Small Round Cell Sarcoma Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-16 Ming Zhao, Xi Zhou, Jing Shan
-
Rethinking Post-colonoscopy Colorectal Cancer Risk: Endoscopist Performance Versus Presence of High-risk Polyps Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-16 Nanette S. van Roermund, Veerle M.H. Coupé, Manon C.W. Spaander, Monique E. van Leerdam, Evelien Dekker, Joep E.G. IJspeert
Current post-polypectomy guidelines set intervals based solely on features of resected polyps. Despite the well-known inverse relationship between both adenoma detection rate (ADR) and proximal serrated polyp detection rate (PSPDR) with post-colonoscopy colorectal cancers (PCCRCs), both quality indicators are not considered when determining surveillance intervals.
-
Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-15 Lisa M. van Velsen, Lesley A. Patmore, Jordan J. Feld, Henry L.Y. Chan, Teerha Piratvisuth, Rong-Nan Chien, Edo J. Dongelmans, Vedran Pavlovic, Leland J. Yee, Willem Pieter Brouwer, Audrey Lau, Bettina E. Hansen, Maria Buti, Qing Xie, Keyur Patel, Scott K. Fung, Harry L.A. Janssen, Milan J. Sonneveld, SONIC-B study group
The presence of metabolic comorbidities is associated with a higher risk of liver-related events in chronic hepatitis B (CHB) patients. However, the association between presence of metabolic comorbidities and the severity of biopsy-proven liver fibrosis is yet unknown.
-
Fulminant Clostridioides difficile Infection Following Fecal Microbiota Spores Compared to Fecal Microbiota Transplant Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-15 Trevor S. Barlowe, Shivani Desai, Ariel E. Sanderford, Thomas Holowka, Anne F. Peery, Sarah K. Mcgill
-
Simplifying Diagnosis of Bile Acid Diarrhea With Clinical and Biochemical Measurements on Blood and Single Stool Sample Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-14 Saam Dilmaghani, Camille Lupianez-Merly, Joelle BouSaba, Priya Vijayvargiya, Irene Busciglio, Monique Ferber, Paula Carlson, Leslie J. Donato, Michael Camilleri
Diagnosis of bile acid diarrhea (BAD) has been based on 48-hour fecal BA excretion; serum 7αC4 (C4) has been used to screen for BAD. Optimal diagnostic cutoffs for C4 and biochemical measurements in a single stool sample are unknown. We sought to examine the relationship between total BA concentration (TBAc) and percent primary BA (%PBA) in a single stool sample and serum C4 in patients with and without
-
Immunogenicity and Efficacy of Subcutaneous Infliximab Monotherapy vs Combination Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-14 Suzanne I. Anjie, Krisztina B. Gecse, Chiara M. Meloni, Andrés Vidal-Itriago, Mark Löwenberg, Geert R. D’Haens
Intravenous (IV) infliximab (IFX) combined with an immunomodulator (combination therapy) outperforms IV IFX monotherapy in terms of clinical, endoscopic, and immunogenicity outcomes in patients with inflammatory bowel disease (IBD). With the advent of subcutaneous (SC) IFX, which is associated with higher serum drug concentrations, it is essential to assess whether SC IFX monotherapy provides similar
-
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related Mortality Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-14 Carolin V. Schneider, Stefan Gross, Sriram Balasubramani, Petra Tomanová, Christina Schrader, Malin Fromme, Mattias Mandorfer, Nurdan Guldiken, Kai Markus Schneider, Georg Lurje, Anastasia Raptis, Helen Ye Rim Huang, Sebastian Mueller, Thomas Reiberger, Pierre Nahon, Quentin M. Anstee, Ann K. Daly, Olivier Govaere, Pavel Strnad
Liver-related mortality represents a growing public health concern, disproportionately affecting younger subjects. Because there are no established tools for early detection of individuals at risk for liver-related death (LRD), we analyzed LRD predictors in the UK Biobank (UKB) data and validated the usefulness of serum insulin-like growth factor-1 (IGF-1).
-
ChatGPT Develops a Natural Language Processing Algorithm for Automated Calculation of Colonoscopy Quality Metrics Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-14 Thomas Y. Li, Nabil M. Mansour
-
A New International Scheme for the Classification and Management of Clinical Outcomes Post-gastric Peroral Endoscopic Myotomy Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-14 Yervant Ichkhanian, Marita Salame, John M. Wo, Thomas V. Nowak, Sarah Stainko, Akira Saito, Robert M. Siwiec, Amr Kais, Joo Ha Hwang, Andrew A. Li, Juliana Yang, Joseph R. Broucek, Tuba Esfandyari, Stephanie Joseph, Michael B. Ujiki, Ashley E. Williams, Jacob Moremen, Zane Gouda, Alexander Schlachterman, Kristina Hugova, Jan Martinek, Calvin X. Geng, Alexander Podboy, Andrew Y. Wang, Michael Lajin
Gastric peroral endoscopic myotomy (G-POEM) is an emerging treatment for gastroparesis, but clinical outcomes can be inconsistent; hence, it is vital to enhance our management strategies for patients with clinical failure.
-
Outcomes of Allogeneic Hematopoietic Stem Cell Transplant in Monogenic Inflammatory Bowel Disease Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-14 Alyssa Baccarella, Trusha Patel, Maire A. Conrad, Marina Macchi, Brooke Boyer, Oliver Pickering, Yelizaveta Borodyanskaya, Shreya Gaddipati, Maya Cohen, Andrea Cubero, Noor Dawany, Jennifer Heimall, Nancy Bunin, Kathleen E. Sullivan, Judith R. Kelsen
Monogenic inflammatory bowel disease (IBD) can result in inborn errors of immunity and intestinal epithelial cell dysfunction, more commonly seen in patients with very early onset IBD (VEO-IBD). Hematopoietic stem cell transplant (HSCT) has emerged as an effective treatment for a subset of patients with monogenic IBD. We sought to evaluate the efficacy and safety of HSCT in these patients. We hypothesized
-
Proactive Drug Monitoring Versus Clinically Based Dosing for Endoscopic Healing in Pediatric Crohn’s Disease Receiving Infliximab Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-14 Ben Kang, Eun Sil Kim, Sujin Choi, Byung-Ho Choe, Jin Soo Moon, Jae Sung Ko, Sangjun Sohn, Yeoun Joo Lee, Yiyoung Kwon, Mi Jin Kim, Tae Yeon Jeon, So Mi Lee, Seunghyun Lee, Youngcheol Ju, Yon Ho Choe
Proactive dosing based on therapeutic drug monitoring (TDM) of adalimumab is associated with higher rates of sustained corticosteroid-free clinical remission (SCFCR) in children with Crohn’s disease (CD) than that with reactive TDM. We aimed to investigate whether proactive dosing of infliximab (IFX) based on TDM is associated with higher rates of endoscopic healing (EH) in pediatric patients with
-
Incidence and Clinical Significance of Recompensation After HCV Cure Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-14 Georg Semmler, Sabela Lens, Álvaro Hidalgo, Sonia Alonso López, Maria Perez-Perez, Elton Dajti, Martin Kabelitz, Paola Zanaga, Benedikt Silvester Hofer, Zoe Marino, Marisa Luisa Manzano, Isabel Payeras, Monica Pons, Angelo Bruni, Alberto Zanetto, Lukas Burghart, Dominik Ecker, Lucie Simonis, Anna Pocurull, Laurenz Fritz, Cristina Collazos, Daniela Neumayer, Lorenz Balcar, Mathias Jachs, Thomas Reiberger
Baveno VII has proposed criteria for cirrhosis recompensation, but their prognostic significance in decompensated patients cured of hepatitis C virus (HCV) deserves further investigation. Thus, we studied the incidence and impact of recompensation after HCV cure as well as its predictors.
-
Long-term Benefits of Resilience-based Integrated Care: Reduced Unplanned Care, Opioid, and Steroid Use in the GRITT-IBD Study Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-14 Yenamala Reddy, Michelle Mendiolaza, Tina Siganporia, Anthony Biello, Ksenia Gorbenko, Laurie Keefer
-
Waist-to-Height Ratio Enhances Predictive Accuracy for Severe Hepatic Steatosis and Advanced Fibrosis: A National Cohort Study Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-14 Sebastian Niezen, Thiago Bosco Mendes, Elliot B. Tapper
-
Feasibility and Acceptability of Noninvasive Stool Testing for Surveillance of Colorectal Polyps in Older Adults Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-14 Suzannah J. Luft, Mirjana Stevanovic, Christopher M. Navas, Douglas J. Robertson, Prabhjot Kaur, Audrey H. Calderwood
-
Medical Posttraumatic Stress in Patients with Digestive Disease Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-13 Madison Simons, Heather Ventura-Witcher, Erika Staneff, Anthony Lembo, Stephen Lupe
-
Impact of Artificial Intelligence on the Gastroenterology Workforce and Practice Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-13 Ali Soroush, Shibani P. Sabnis, Shivan J. Mehta, Shazia Mehmood Siddique
-
Global Health Policies for Hepatocellular Carcinoma: A Cross-Sectional Study Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-12 Douglas Chee, Christen En Ya Ong, Darren J.H. Tan, Jörn M. Schattenberg, George N. Ioannou, Daniel Q. Huang, HCC Policy Study Group, Ng Cheng Han, Rachid Ould Gougam, Federico Piñero, Ken Liu, Simone I. Strasser, Sven M. Francque, M.L. Ferraz, Antonin Wilson Ndjitoyap Ndam, Marc Bilodeau, Jie Li, Fanpu Ji, Andres Gomez-Aldana, Robin German Prieto-Ortiz, Petr Hříbek, Mbendi Nlombi Charles, Mohamed El-Kassas
-
Remission of Sequestrant-refractory Bile Acid Diarrhea in Patients on Liraglutide With Pragmatic Dose Escalation: A Case Series Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-12 Christian Borup, Lars Kristian Munck, Nynne Nyboe Andersen
-
Colonic Ischemia Due to Splanchnic Arteriovenous Malformation Treated by Embolization Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-12 Shuhei Kato, Kana Yamaguchi, Takahiro Shimizu
-
Practice Management: GI Locum Tenens and the Fair Market Value of Hospital Work Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-12 Kimberly Zibert, Kristin Gaffney, J. Andy Tau
-
Too Old to Treat? Rethinking Steroid-sparing Therapy in Elderly-onset Inflammatory Bowel Disease Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-12 Rie Louise Møller Nordestgaard, Mads Damsgaard Wewer, Johan Burisch
-
Reply Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Takefumi Kimura, Nobuharu Tamaki, Masayuki Kurosaki
-
Verrucous Carcinoma of the Esophagus Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 D. Chamil Codipilly, Cadman L. Leggett
-
Iron Pill Gastritis Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Grace Meulman, Joo-Shik Shin, Emily Nash
-
Letter to Goodsall et al. Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Jean-Yves Mary, David Laharie
-
The Index of Severity for Eosinophilic Esophagitis Helps Predict Treatment Response to Dupilumab Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Corey J. Ketchem, Anwesh Dash, Gary W. Falk, Evan S. Dellon, Kristle l. Lynch
-
Reply Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Sailish Honap, Kamal Patel, Laurent Peyrin-Biroulet
-
Determining Cirrhosis Status in Candidates for Resmetirom Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Mazen Noureddin, Mena Bansal, Mary E. Rinella
-
American Gastroenterological Association Policy Priorities for Our 2025 Legislative Agenda Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Omeed Alipour, Sheila D. Rustgi, Kathleen Teixeira, Leslie Narramore, AGA Government Affairs Committee, Shazia Mehmood Siddique
-
Ammonia Levels After Transjugular Intrahepatic Portosystemic Shunt Insertion Identify Patients at High Risk of Hepatic Encephalopathy Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Christian Labenz, Laura Schmidtke, Michael B. Pitton, Peter R. Galle, Eva M. Schleicher, Simon J. Gairing
-
Long-term Use of Topical Steroids in Eosinophilic Esophagitis: Efficacy, Safety, and Unanswered Questions Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Yash Choksi, David Katzka
-
Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Kavish R. Patidar, Ruben Hernaez, Yan Liu, George Cholankeril, Jennifer R. Kramer, Thom Taylor, Prasun Jalal, Tzu-Hao Lee, Avegail G. Flores, Giuseppe Cullaro, Andrew S. Allegretti, Pere Gines, Fasiha Kanwal
Little is known about ambulatory acute kidney injury (A-AKI), which develops in an outpatient setting.
-
Redundancy of the Transverse Colon: Documentation of Length and Prolonged Retention Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Ayah Matar, Nada Abdelnaem, Duane Burton, Robert Cima, Michael Camilleri
-
Dynamic Steatotic Liver Disease Classification Calls for Adaptive Clinical Trial Designs and Longitudinal Monitoring Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Weixiong Zhu, Yanxi Mu, Wence Zhou
-
Colonic Leiomyoma: Endoscopic Resection and Diagnosis of a Rare Lesion Found During Routine Colonoscopy Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Rafia Irfan Waheed, Andrea V. Kelsch, Ahmed T. Kurdi
-
Long-Term Mortality After Cholecystectomy in a Nationwide Cohort of Swedish Individuals Between 1969 and 2016 Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Louise Emilsson, Amit D. Joshi, Jonas F. Ludvigsson
Few studies have reported overall and subgroup long-term survival after cholecystectomy.
-
Dissecting AI Chatbot Outputs in Gastroenterology: Implications for Celiac Disease Management Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Ernest Saenz, Andres Gomez Aldana
-
Refining Donor Selection for FMT in UC: The Role of Chromobacteriaceae and Other Underrecognized Pro-inflammatory Taxa Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Hong Zhang, Jiaxin Li, Hu Zhang
-
Reconsidering the Relationship Between Early Post Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy and Mortality: Are We Still Missing Something? Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-10 Dario Saltini, Silvia Nardelli, Filippo Schepis
-
Langerhans Cell Histiocytosis of the Gastrointestinal Tract Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-09 Andreas Probst, Irene Kleinlein, Helmut Messmann
-
Incidental Findings During Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2025-05-09 Darine Daher, Meena Tadros, Manasa Narasimman, Sruthi Yekkaluri, Ruben Hernaez, Amit G. Singal, North American Liver Cancer Consortium, Chaitra Banala, Neehar D. Parikh, Ju Dong Yang, Lisa B. VanWagner, Jeremy Louissaint